MarketBeat
Sun, March 22, 2026 astatine 1:01 PM CDT 7 min read
-
Tandem is shifting supplies into the pharmacy channel, which already helped assistance Q4 gross borderline to 58% and is expected to thrust the institution to astir 60%–65% gross margin sooner than antecedently planned, with pharmacy income projected to scope astir 70% of full income implicit the pursuing 2–3 years.
-
The institution has contracts with the 3 large PBMs (covering ~80% of lives) and is pursuing a pay-as-you-go exemplary with a moving net-price presumption adjacent $350/month and plans that could fto patients get a pump astatine nary outgo to little adoption barriers.
-
Tandem remains connected way to taxable the Mobi tubeless successful Q2 and motorboat successful H2 2026 (7‑day extended‑wear), portion besides advancing Sigi arsenic a next‑gen instrumentality and preparing planetary rollouts and integrations (FreeStyle Libre 3, Dexcom updates) with ADA arsenic a near-term catalyst.
-
Interested successful Tandem Diabetes Care, Inc.? Here are 5 stocks we similar better.
Executives from Tandem Diabetes Care (NASDAQ:TNDM) outlined however a displacement toward the pharmacy channel, an expanding merchandise portfolio, and planetary buildout are expected to reshape the company’s gross premix and borderline illustration implicit the adjacent respective years during an capitalist treatment hosted by Oppenheimer aesculapian instrumentality expert Suraj Kalia.
CFO Leigh Vosseller said Tandem has already begun to spot fiscal benefits from aboriginal steps into the pharmacy channel. She noted that past twelvemonth marked the company’s archetypal determination into pharmacy, initially with the Mobi level utilizing a reimbursement attack that resembled the durable aesculapian instrumentality (DME) model. Midway done the year, she said absorption saw “great validation” of assumptions astir pharmacy’s benefits for some patients and physicians, prompting Tandem to determination faster than planned by adding t:slim supplies to the pharmacy channel.
→ Expedia Stock Turns Volatile After Rally. Where Does It Go Next?
In the 4th quarter, Vosseller said pharmacy measurement remained small—less than 5% of customers ordering supplies done pharmacy—yet inactive represented astir 7% of institution sales. She added that the institution recorded a “really bully gross borderline benefit,” including its highest gross borderline to day astatine 58% successful Q4.
Looking ahead, Vosseller described a much important concern exemplary displacement starting successful 2026, successful which supplies are expected to determination into the pharmacy transmission and patients would beryllium capable to get a pump astatine nary outgo if they take Tandem. Under that model, she said the institution expects astir 10% of customers to beryllium purchasing supplies via pharmacy connected mean crossed 2026, translating to pharmacy income of astir 15% for the year. Over the pursuing 2 to 3 years, she said Tandem expects pharmacy income to emergence to astir 70% of full sales.

2 hours ago
2





English (CA) ·
English (US) ·
Spanish (MX) ·